Skip to content

Effect of Perioperative OPEP Therapy on Post-operative Pulmonary Complications

Effectiveness of Perioperative Oscillating Positive Expiratory Pressure (OPEP) Therapy in Reduction of Post-operative Respiratory Morbidity in Patients Undergoing Colorectal Surgery: a Pilot Randomized Control Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05134610
Enrollment
150
Registered
2021-11-26
Start date
2022-03-31
Completion date
2023-10-31
Last updated
2022-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Complication, Surgery, Surgery--Complications

Keywords

oscillating pulmonary expiratory pressure therapy, OPEP

Brief summary

For patients undergoing colorectal surgery, post-operative pulmonary complications (PPCs) are common. PPCs are associated with increased morbidity and mortality, as well as prolonged hospital stays and healthcare costs. Pulmonary exercise in the pre-operative setting is thought to improve pulmonary fitness and decrease incidence of PPCs. Use of an oscillating positive expiratory pressure (OPEP) device sees patients improve their respiratory fitness through prescribed usage of a handheld instrument that exercises pulmonary muscles while breathing. Here, the investigators propose a pilot randomized-controlled trial (RCT) to evaluate the feasibility of a large scale study that would examine the effect of preoperative OPEP device exercises in preventing PPCs for patients undergoing elective colorectal surgery.

Interventions

DEVICEAEROBIKA POSITIVE EXPIRATORY PRESSURE DEVICE

Intervention arm patients use the OPEP device twice daily for 2 weeks before and after surgery

Sponsors

Western University, Canada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must be 18 years of age or older, and scheduled for an elective colorectal procedure at London Health Science Center (LHSC). Informed consent must be obtained.

Exclusion criteria

* Patients unable to perform written consent will be excluded. The investigators will not include colorectal procedures performed for urgent or emergent indications. Patients with advanced pulmonary disease necessitating home oxygen pre-operatively will be excluded. Patients that are pregnant will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Trial feasibility: capacity for recruitment18 monthsAbility of clinics to recruit patients in a timely manner. To be reported as a percent of the desired number of patients recruited over an 18 month period.
Trial feasibility: device adherence18 monthsAdherence of enrolled patients to usage of the OPEP device. To be reported as percent of patients returning a complete logbook detailing their consistent use of the OPEP device pre-op and post-op.
Trial feasibility: data collection18 months3\) Completeness of data collected from enrolled patients medical record. To be reported as a percent of recruited patients with complete datasets following the trials completion. Used to identify gaps in data for a future fully powered trial.
Trial feasibility: limited efficacy of the OPEP device18 monthsLimited efficacy of the OPEP device to decrease post-operative pulmonary complications (PPCs). PPCs represents a composite outcome including atelectasis, pneumonia, prolonged requirement for supplemental oxygen, and respiratory failure.

Contacts

Primary ContactJeff Metz, MD
jeffmetz2@gmail.com4169533991
Backup ContactNawar Alkhamesi, MD
Nawar.Alkhamesi@lhsc.on.ca1-519-663-3985

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026